CKS2 and glioma: According to our experimented data, we found that cyclin‐dependent kinase subunit2 (CKS2) promoted malignant phenotypes and EMT‐like process in glioma through TGFβ/SMAD signaling pathway; besides, many researches also supported our opinion.